You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Cryogenic Grinding System for the High Productivity Grinding of Advanced Materials

    SBC: CREARE LLC            Topic: DLA09001

    High performance metals, ceramics, and hard coatings are used in military applications to enhance the performance of key systems needed by the warfighter. One of the most prevalent operations to remove material, achieve the desired surface finish, or enhance part quality is bulk and finish grinding. For typical cutting speeds, conventional synthetic or oil-based coolants are sufficient to remove ...

    SBIR Phase II 2011 Department of DefenseDefense Logistics Agency
  2. A Novel Microfludic Device for Drug Toxicity Studies

    SBC: CFD RESEARCH CORPORATION            Topic: CBD10103

    Current drug discovery and development efforts are severely limited by expensive animal trials and oversimplified in vitro models. Results obtained from in vitro models are not predictive of in vivo toxicity owing to significant difference from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device that reproduces the physiological ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  3. Botulinum Toxin Plantibodies

    SBC: Planet Biotechnology Incorporated            Topic: CBD03103

    The primary goals of this Phase II application are to successfully manufacture pilot-scale quantities of neutralizing anti-botulinum toxin antibodies in plants, and to complete preclinical studies with these antibodies. Our collaborator, Dr. James D. Mar

    SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense
  4. 3D Microfluidic Platform for in vitro Hematopoietic Stem Cell (HSC) Culture

    SBC: Physical Optics Corporation            Topic: CBD10103

    Poor drug candidates are often identified late in the drug development process (e.g., in the preclinical and clinical phases) and contribute significantly to the high cost and low yield of drug discovery. As a result, new tools are needed to accelerate the assessment of drug candidate toxicity earlier in the drug development process. To address this Chemical/Bio Defense (CBD) need, Physical Optics ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  5. Microfluidic High-throughput Platform for Determining Kinetic Constants of Enzyme Variants

    SBC: CFD RESEARCH CORPORATION            Topic: CBD10107

    Current high-throughput platforms rely on labeled substrates that produce detectable spectroscopic signals upon reaction for monitoring enzyme catalytic activity. Add to that the high price tag for these instruments, ranging from several hundred thousand to millions of dollars, and there is a clear need for alternate solutions for a label-free, low-cost, high-throughput enzyme screening platform. ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  6. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: SURFACE OPTICS CORP.            Topic: CBD171002

    A program to develop a compact, MLA-based, LWIR, full-motion-video hyperspectral imager for chemical detection is proposed. The proposed Hyperspectral Chemical Imaging Sensor (HyCIS) builds upon Surface Optics’ real-time hyperspectral imaging activities, including our 3D full-motion-video spectral imaging (FMV-SI) technology and our MIDIS hyperspectral image processor. Simultaneously sampling 16 ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  7. MicroLens Hyperspectral Imager for Standoff Chemical Detection

    SBC: SA PHOTONICS, LLC            Topic: CBD171002

    SA Photonics is please to submit the proposal for the HawkEye compact LWIR hyperspectral imaging system. HawkEye leverages SA Photonics previous visible, SWIR, and LWIR programs to result in a compact, hand held, battery operated hyperspectral imager in a low cost design approach. Furthermore, HawkEye will leverages SA Photonics expertise in warfighter body worn equipment and ground troop personal ...

    SBIR Phase II 2019 Department of DefenseOffice for Chemical and Biological Defense
  8. Miniature Residual Life Indicator

    SBC: Physical Optics Corporation            Topic: CBD10106

    To address the Chemical and Biological Defense (CBD) need for a residual life indicator (RLI) capable of determining the degradation in physical adsorption and reactive capacity arising from battlefield contaminants and exposure to the elements, Physical Optics Corporation (POC) proposes to continue the development of a new Miniature Residual Life Indicator (MRLIN). MRLIN is based on impedance spe ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  9. MOEMS Miniaturized Real-time Visible/UV Spectrometer

    SBC: MORGAN RESEARCH CORP.            Topic: CBD02300

    This Phase II SBIR proposal is for the development of a miniaturized real-time visible/UV spectrometer prototype based on micro-opto-electro-mechanical systems (MOEMS) technology. Use of MOEMS technology enables orders of magnitude reductions in size, we

    SBIR Phase II 2004 Department of DefenseOffice for Chemical and Biological Defense
  10. Multifunctional Antisense Therapeutics Nanocarrier and Inhalation Device

    SBC: Physical Optics Corporation            Topic: CBD10102

    To address the CBD need for improved formulations to enhance the ease of use and bioavailability of antisense therapeutics, Physical Optics Corporation (POC) proposes to advance development of a Multifunctional Antisense Therapeutics Nanocarrier and Inhalation Device (MATEN). This proposed system is based on a new dry powder formulation and a novel design of an inhaler that uses mature components ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government